Verition Fund Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $914K | Sell |
4,176
-2,206
| -35% | -$483K | ﹤0.01% | 1915 |
|
2025
Q1 | $1.43M | Buy |
6,382
+4,883
| +326% | +$1.09M | 0.01% | 1403 |
|
2024
Q4 | $491K | Sell |
1,499
-3,669
| -71% | -$1.2M | ﹤0.01% | 1899 |
|
2024
Q3 | $1.55M | Buy |
5,168
+4,066
| +369% | +$1.22M | 0.01% | 1106 |
|
2024
Q2 | $363K | Sell |
1,102
-231
| -17% | -$76.1K | ﹤0.01% | 1622 |
|
2024
Q1 | $527K | Sell |
1,333
-886
| -40% | -$351K | ﹤0.01% | 1441 |
|
2023
Q4 | $781K | Buy |
2,219
+1,595
| +256% | +$562K | 0.01% | 983 |
|
2023
Q3 | $234K | Sell |
624
-660
| -51% | -$248K | ﹤0.01% | 1551 |
|
2023
Q2 | $491K | Buy |
1,284
+629
| +96% | +$241K | 0.01% | 1071 |
|
2023
Q1 | $227K | Buy |
+655
| New | +$227K | ﹤0.01% | 1544 |
|
2022
Q4 | – | Sell |
-6,230
| Closed | -$1.53M | – | 2229 |
|
2022
Q3 | $1.53M | Buy |
6,230
+4,167
| +202% | +$1.03M | 0.02% | 908 |
|
2022
Q2 | $624K | Buy |
+2,063
| New | +$624K | 0.01% | 1261 |
|
2019
Q4 | – | Sell |
-7,146
| Closed | -$1.01M | – | 1241 |
|
2019
Q3 | $1.01M | Buy |
+7,146
| New | +$1.01M | 0.03% | 326 |
|
2019
Q1 | – | Sell |
-2,075
| Closed | -$203K | – | 1261 |
|
2018
Q4 | $203K | Sell |
2,075
-9,568
| -82% | -$936K | 0.01% | 675 |
|
2018
Q3 | $1.44M | Buy |
+11,643
| New | +$1.44M | 0.05% | 399 |
|
2018
Q2 | – | Sell |
-6,549
| Closed | -$578K | – | 1278 |
|
2018
Q1 | $578K | Buy |
6,549
+2,413
| +58% | +$213K | 0.04% | 539 |
|
2017
Q4 | $408K | Buy |
+4,136
| New | +$408K | 0.04% | 516 |
|
2017
Q3 | – | Sell |
-8,051
| Closed | -$761K | – | 1327 |
|
2017
Q2 | $761K | Buy |
8,051
+3,195
| +66% | +$302K | 0.07% | 224 |
|
2017
Q1 | $396K | Buy |
+4,856
| New | +$396K | 0.04% | 643 |
|
2016
Q3 | – | Sell |
-5,942
| Closed | -$451K | – | 1229 |
|
2016
Q2 | $451K | Buy |
+5,942
| New | +$451K | 0.06% | 364 |
|